SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'EPJ'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UW6_A_NCTA1208_1 (ACETYLCHOLINE-BINDING PROTEIN) |
5fjv | NEURONALACETYLCHOLINERECEPTOR SUBUNITALPHA-2 (Homosapiens) | 4 / 8 | TYR A 122TRP A 178THR A 179TYR A 226 | EPJ A 300 (-4.6A)EPJ A 300 (-3.7A)EPJ A 300 (-3.3A)EPJ A 300 (-3.7A) | 0.36A | 1uw6A-5fjvA:22.71uw6B-5fjvA:23.5 | 1uw6A-5fjvA:28.311uw6B-5fjvA:28.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UW6_B_NCTB1206_1 (ACETYLCHOLINE-BINDING PROTEIN) |
5fjv | NEURONALACETYLCHOLINERECEPTOR SUBUNITALPHA-2 (Homosapiens) | 5 / 9 | TYR A 122TRP A 178THR A 179TYR A 219TYR A 226 | EPJ A 300 (-4.6A)EPJ A 300 (-3.7A)EPJ A 300 (-3.3A)EPJ A 300 (-3.7A)EPJ A 300 (-3.7A) | 0.51A | 1uw6B-5fjvA:23.41uw6C-5fjvA:23.1 | 1uw6B-5fjvA:28.311uw6C-5fjvA:28.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UW6_D_NCTD1208_1 (ACETYLCHOLINE-BINDING PROTEIN) |
5fjv | NEURONALACETYLCHOLINERECEPTOR SUBUNITALPHA-2 (Homosapiens) | 4 / 8 | TYR A 122TRP A 178THR A 179TYR A 226 | EPJ A 300 (-4.6A)EPJ A 300 (-3.7A)EPJ A 300 (-3.3A)EPJ A 300 (-3.7A) | 0.35A | 1uw6D-5fjvA:22.81uw6E-5fjvA:22.9 | 1uw6D-5fjvA:28.311uw6E-5fjvA:28.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UW6_F_NCTF1208_1 (ACETYLCHOLINE-BINDING PROTEIN) |
5fjv | NEURONALACETYLCHOLINERECEPTOR SUBUNITALPHA-2 (Homosapiens) | 5 / 10 | TYR A 122TRP A 178THR A 179TYR A 219TYR A 226 | EPJ A 300 (-4.6A)EPJ A 300 (-3.7A)EPJ A 300 (-3.3A)EPJ A 300 (-3.7A)EPJ A 300 (-3.7A) | 0.48A | 1uw6F-5fjvA:22.71uw6G-5fjvA:22.9 | 1uw6F-5fjvA:28.311uw6G-5fjvA:28.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UW6_G_NCTG1206_1 (ACETYLCHOLINE-BINDING PROTEIN) |
5fjv | NEURONALACETYLCHOLINERECEPTOR SUBUNITALPHA-2 (Homosapiens) | 4 / 8 | TYR A 122TRP A 178THR A 179TYR A 226 | EPJ A 300 (-4.6A)EPJ A 300 (-3.7A)EPJ A 300 (-3.3A)EPJ A 300 (-3.7A) | 0.38A | 1uw6G-5fjvA:22.91uw6H-5fjvA:22.9 | 1uw6G-5fjvA:28.311uw6H-5fjvA:28.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UW6_H_NCTH1206_1 (ACETYLCHOLINE-BINDING PROTEIN) |
5fjv | NEURONALACETYLCHOLINERECEPTOR SUBUNITALPHA-2 (Homosapiens) | 5 / 10 | TYR A 122TRP A 178THR A 179TYR A 219TYR A 226 | EPJ A 300 (-4.6A)EPJ A 300 (-3.7A)EPJ A 300 (-3.3A)EPJ A 300 (-3.7A)EPJ A 300 (-3.7A) | 0.48A | 1uw6H-5fjvA:22.91uw6I-5fjvA:23.0 | 1uw6H-5fjvA:28.311uw6I-5fjvA:28.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UW6_J_NCTJ1206_1 (ACETYLCHOLINE-BINDING PROTEIN) |
5fjv | NEURONALACETYLCHOLINERECEPTOR SUBUNITALPHA-2 (Homosapiens) | 5 / 9 | TYR A 122TRP A 178THR A 179TYR A 219TYR A 226 | EPJ A 300 (-4.6A)EPJ A 300 (-3.7A)EPJ A 300 (-3.3A)EPJ A 300 (-3.7A)EPJ A 300 (-3.7A) | 0.45A | 1uw6F-5fjvA:22.71uw6J-5fjvA:23.1 | 1uw6F-5fjvA:28.311uw6J-5fjvA:28.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UW6_M_NCTM1208_1 (ACETYLCHOLINE-BINDING PROTEIN) |
5fjv | NEURONALACETYLCHOLINERECEPTOR SUBUNITALPHA-2 (Homosapiens) | 5 / 10 | TYR A 122TRP A 178THR A 179TYR A 219TYR A 226 | EPJ A 300 (-4.6A)EPJ A 300 (-3.7A)EPJ A 300 (-3.3A)EPJ A 300 (-3.7A)EPJ A 300 (-3.7A) | 0.57A | 1uw6M-5fjvA:22.81uw6N-5fjvA:22.8 | 1uw6M-5fjvA:28.311uw6N-5fjvA:28.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UW6_N_NCTN1208_1 (ACETYLCHOLINE-BINDING PROTEIN) |
5fjv | NEURONALACETYLCHOLINERECEPTOR SUBUNITALPHA-2 (Homosapiens) | 5 / 10 | TYR A 122TRP A 178THR A 179TYR A 219TYR A 226 | EPJ A 300 (-4.6A)EPJ A 300 (-3.7A)EPJ A 300 (-3.3A)EPJ A 300 (-3.7A)EPJ A 300 (-3.7A) | 0.51A | 1uw6N-5fjvA:22.81uw6O-5fjvA:23.2 | 1uw6N-5fjvA:28.311uw6O-5fjvA:28.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UW6_O_NCTO1206_1 (ACETYLCHOLINE-BINDING PROTEIN) |
5fjv | NEURONALACETYLCHOLINERECEPTOR SUBUNITALPHA-2 (Homosapiens) | 5 / 9 | TYR A 122TRP A 178THR A 179TYR A 219TYR A 226 | EPJ A 300 (-4.6A)EPJ A 300 (-3.7A)EPJ A 300 (-3.3A)EPJ A 300 (-3.7A)EPJ A 300 (-3.7A) | 0.42A | 1uw6K-5fjvA:22.91uw6O-5fjvA:23.2 | 1uw6K-5fjvA:28.311uw6O-5fjvA:28.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UW6_P_NCTP1206_1 (ACETYLCHOLINE-BINDING PROTEIN) |
5fjv | NEURONALACETYLCHOLINERECEPTOR SUBUNITALPHA-2 (Homosapiens) | 4 / 8 | TYR A 122TRP A 178THR A 179TYR A 226 | EPJ A 300 (-4.6A)EPJ A 300 (-3.7A)EPJ A 300 (-3.3A)EPJ A 300 (-3.7A) | 0.33A | 1uw6P-5fjvA:23.11uw6Q-5fjvA:23.1 | 1uw6P-5fjvA:28.311uw6Q-5fjvA:28.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UW6_Q_NCTQ1206_1 (ACETYLCHOLINE-BINDING PROTEIN) |
5fjv | NEURONALACETYLCHOLINERECEPTOR SUBUNITALPHA-2 (Homosapiens) | 5 / 10 | TYR A 122TRP A 178THR A 179TYR A 219TYR A 226 | EPJ A 300 (-4.6A)EPJ A 300 (-3.7A)EPJ A 300 (-3.3A)EPJ A 300 (-3.7A)EPJ A 300 (-3.7A) | 0.46A | 1uw6Q-5fjvA:23.11uw6R-5fjvA:22.8 | 1uw6Q-5fjvA:28.311uw6R-5fjvA:28.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UW6_S_NCTS1206_1 (ACETYLCHOLINE-BINDING PROTEIN) |
5fjv | NEURONALACETYLCHOLINERECEPTOR SUBUNITALPHA-2 (Homosapiens) | 5 / 10 | TYR A 122TRP A 178THR A 179TYR A 219TYR A 226 | EPJ A 300 (-4.6A)EPJ A 300 (-3.7A)EPJ A 300 (-3.3A)EPJ A 300 (-3.7A)EPJ A 300 (-3.7A) | 0.40A | 1uw6S-5fjvA:22.91uw6T-5fjvA:22.9 | 1uw6S-5fjvA:28.311uw6T-5fjvA:28.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UW6_T_NCTT1208_1 (ACETYLCHOLINE-BINDING PROTEIN) |
5fjv | NEURONALACETYLCHOLINERECEPTOR SUBUNITALPHA-2 (Homosapiens) | 4 / 8 | TYR A 122TRP A 178THR A 179TYR A 226 | EPJ A 300 (-4.6A)EPJ A 300 (-3.7A)EPJ A 300 (-3.3A)EPJ A 300 (-3.7A) | 0.39A | 1uw6P-5fjvA:23.11uw6T-5fjvA:22.9 | 1uw6P-5fjvA:28.311uw6T-5fjvA:28.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2WNC_A_TKTA300_1 (SOLUBLEACETYLCHOLINERECEPTOR) |
5fjv | NEURONALACETYLCHOLINERECEPTOR SUBUNITALPHA-2 (Homosapiens) | 6 / 10 | TYR A 122TRP A 178TYR A 219CSS A 221CSS A 222TYR A 226 | EPJ A 300 (-4.6A)EPJ A 300 (-3.7A)EPJ A 300 (-3.7A)EPJ A 300 ( 4.2A)EPJ A 300 ( 4.2A)EPJ A 300 (-3.7A) | 1.16A | 2wncA-5fjvA:22.52wncE-5fjvA:15.1 | 2wncA-5fjvA:30.472wncE-5fjvA:30.47 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2XZ5_A_ACHA1210_0 (SOLUBLEACETYLCHOLINERECEPTOR) |
5fjv | NEURONALACETYLCHOLINERECEPTOR SUBUNITALPHA-2 (Homosapiens) | 4 / 6 | TYR A 122TRP A 178TYR A 219TYR A 226 | EPJ A 300 (-4.6A)EPJ A 300 (-3.7A)EPJ A 300 (-3.7A)EPJ A 300 (-3.7A) | 0.70A | 2xz5A-5fjvA:22.82xz5B-5fjvA:22.7 | 2xz5A-5fjvA:31.392xz5B-5fjvA:31.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2XZ5_B_ACHB1210_0 (SOLUBLEACETYLCHOLINERECEPTOR) |
5fjv | NEURONALACETYLCHOLINERECEPTOR SUBUNITALPHA-2 (Homosapiens) | 4 / 7 | TYR A 122TRP A 178TYR A 219TYR A 226 | EPJ A 300 (-4.6A)EPJ A 300 (-3.7A)EPJ A 300 (-3.7A)EPJ A 300 (-3.7A) | 0.68A | 2xz5B-5fjvA:22.72xz5E-5fjvA:22.7 | 2xz5B-5fjvA:31.392xz5E-5fjvA:31.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2XZ5_C_ACHC1210_0 (SOLUBLEACETYLCHOLINERECEPTOR) |
5fjv | NEURONALACETYLCHOLINERECEPTOR SUBUNITALPHA-2 (Homosapiens) | 4 / 8 | TYR A 122TRP A 178TYR A 219TYR A 226 | EPJ A 300 (-4.6A)EPJ A 300 (-3.7A)EPJ A 300 (-3.7A)EPJ A 300 (-3.7A) | 0.69A | 2xz5A-5fjvA:22.82xz5C-5fjvA:22.8 | 2xz5A-5fjvA:31.392xz5C-5fjvA:31.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2XZ5_D_ACHD1210_0 (SOLUBLEACETYLCHOLINERECEPTOR) |
5fjv | NEURONALACETYLCHOLINERECEPTOR SUBUNITALPHA-2 (Homosapiens) | 4 / 8 | TYR A 122TRP A 178TYR A 219TYR A 226 | EPJ A 300 (-4.6A)EPJ A 300 (-3.7A)EPJ A 300 (-3.7A)EPJ A 300 (-3.7A) | 0.70A | 2xz5C-5fjvA:22.82xz5D-5fjvA:22.8 | 2xz5C-5fjvA:31.392xz5D-5fjvA:31.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2XZ5_E_ACHE1210_0 (SOLUBLEACETYLCHOLINERECEPTOR) |
5fjv | NEURONALACETYLCHOLINERECEPTOR SUBUNITALPHA-2 (Homosapiens) | 4 / 7 | TYR A 122TRP A 178TYR A 219TYR A 226 | EPJ A 300 (-4.6A)EPJ A 300 (-3.7A)EPJ A 300 (-3.7A)EPJ A 300 (-3.7A) | 0.68A | 2xz5D-5fjvA:22.82xz5E-5fjvA:22.7 | 2xz5D-5fjvA:31.392xz5E-5fjvA:31.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3WIP_A_ACHA301_0 (ACETYLCHOLINE-BINDING PROTEIN) |
5fjv | NEURONALACETYLCHOLINERECEPTOR SUBUNITALPHA-2 (Homosapiens) | 5 / 7 | TYR A 122TRP A 178THR A 179TYR A 219TYR A 226 | EPJ A 300 (-4.6A)EPJ A 300 (-3.7A)EPJ A 300 (-3.3A)EPJ A 300 (-3.7A)EPJ A 300 (-3.7A) | 0.67A | 3wipA-5fjvA:22.83wipB-5fjvA:22.7 | 3wipA-5fjvA:27.353wipB-5fjvA:27.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3WIP_B_ACHB301_0 (ACETYLCHOLINE-BINDING PROTEIN) |
5fjv | NEURONALACETYLCHOLINERECEPTOR SUBUNITALPHA-2 (Homosapiens) | 5 / 8 | TYR A 122TRP A 178THR A 179TYR A 219TYR A 226 | EPJ A 300 (-4.6A)EPJ A 300 (-3.7A)EPJ A 300 (-3.3A)EPJ A 300 (-3.7A)EPJ A 300 (-3.7A) | 0.66A | 3wipB-5fjvA:22.63wipC-5fjvA:22.9 | 3wipB-5fjvA:27.353wipC-5fjvA:27.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3WIP_C_ACHC301_0 (ACETYLCHOLINE-BINDING PROTEIN) |
5fjv | NEURONALACETYLCHOLINERECEPTOR SUBUNITALPHA-2 (Homosapiens) | 5 / 8 | TYR A 122TRP A 178THR A 179TYR A 219TYR A 226 | EPJ A 300 (-4.6A)EPJ A 300 (-3.7A)EPJ A 300 (-3.3A)EPJ A 300 (-3.7A)EPJ A 300 (-3.7A) | 0.66A | 3wipC-5fjvA:22.93wipD-5fjvA:22.9 | 3wipC-5fjvA:27.353wipD-5fjvA:27.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3WIP_D_ACHD301_0 (ACETYLCHOLINE-BINDING PROTEIN) |
5fjv | NEURONALACETYLCHOLINERECEPTOR SUBUNITALPHA-2 (Homosapiens) | 5 / 8 | TYR A 122TRP A 178THR A 179TYR A 219TYR A 226 | EPJ A 300 (-4.6A)EPJ A 300 (-3.7A)EPJ A 300 (-3.3A)EPJ A 300 (-3.7A)EPJ A 300 (-3.7A) | 0.65A | 3wipD-5fjvA:22.93wipE-5fjvA:22.8 | 3wipD-5fjvA:27.353wipE-5fjvA:27.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3WIP_E_ACHE301_0 (ACETYLCHOLINE-BINDING PROTEIN) |
5fjv | NEURONALACETYLCHOLINERECEPTOR SUBUNITALPHA-2 (Homosapiens) | 5 / 8 | TYR A 122TRP A 178THR A 179TYR A 219TYR A 226 | EPJ A 300 (-4.6A)EPJ A 300 (-3.7A)EPJ A 300 (-3.3A)EPJ A 300 (-3.7A)EPJ A 300 (-3.7A) | 0.70A | 3wipA-5fjvA:22.83wipE-5fjvA:22.8 | 3wipA-5fjvA:27.353wipE-5fjvA:27.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3WIP_F_ACHF301_0 (ACETYLCHOLINE-BINDING PROTEIN) |
5fjv | NEURONALACETYLCHOLINERECEPTOR SUBUNITALPHA-2 (Homosapiens) | 5 / 7 | TYR A 122TRP A 178THR A 179TYR A 219TYR A 226 | EPJ A 300 (-4.6A)EPJ A 300 (-3.7A)EPJ A 300 (-3.3A)EPJ A 300 (-3.7A)EPJ A 300 (-3.7A) | 0.64A | 3wipF-5fjvA:22.63wipG-5fjvA:23.5 | 3wipF-5fjvA:27.353wipG-5fjvA:27.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3WIP_G_ACHG301_0 (ACETYLCHOLINE-BINDING PROTEIN) |
5fjv | NEURONALACETYLCHOLINERECEPTOR SUBUNITALPHA-2 (Homosapiens) | 5 / 8 | TYR A 122TRP A 178THR A 179TYR A 219TYR A 226 | EPJ A 300 (-4.6A)EPJ A 300 (-3.7A)EPJ A 300 (-3.3A)EPJ A 300 (-3.7A)EPJ A 300 (-3.7A) | 0.64A | 3wipG-5fjvA:23.53wipH-5fjvA:22.7 | 3wipG-5fjvA:27.353wipH-5fjvA:27.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3WIP_H_ACHH301_0 (ACETYLCHOLINE-BINDING PROTEIN) |
5fjv | NEURONALACETYLCHOLINERECEPTOR SUBUNITALPHA-2 (Homosapiens) | 5 / 9 | TYR A 122TRP A 178THR A 179TYR A 219TYR A 226 | EPJ A 300 (-4.6A)EPJ A 300 (-3.7A)EPJ A 300 (-3.3A)EPJ A 300 (-3.7A)EPJ A 300 (-3.7A) | 0.67A | 3wipH-5fjvA:22.73wipI-5fjvA:22.9 | 3wipH-5fjvA:27.353wipI-5fjvA:27.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3WIP_J_ACHJ301_0 (ACETYLCHOLINE-BINDING PROTEIN) |
5fjv | NEURONALACETYLCHOLINERECEPTOR SUBUNITALPHA-2 (Homosapiens) | 5 / 8 | TYR A 122TRP A 178THR A 179TYR A 219TYR A 226 | EPJ A 300 (-4.6A)EPJ A 300 (-3.7A)EPJ A 300 (-3.3A)EPJ A 300 (-3.7A)EPJ A 300 (-3.7A) | 0.65A | 3wipF-5fjvA:22.63wipJ-5fjvA:23.0 | 3wipF-5fjvA:27.353wipJ-5fjvA:27.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4AFT_D_QMRD301_1 (SOLUBLEACETYLCHOLINERECEPTOR) |
5fjv | NEURONALACETYLCHOLINERECEPTOR SUBUNITALPHA-2 (Homosapiens) | 4 / 8 | TYR A 122TRP A 178TYR A 219TYR A 226 | EPJ A 300 (-4.6A)EPJ A 300 (-3.7A)EPJ A 300 (-3.7A)EPJ A 300 (-3.7A) | 0.48A | 4aftD-5fjvA:22.64aftE-5fjvA:15.1 | 4aftD-5fjvA:31.394aftE-5fjvA:31.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4BQT_C_C5EC301_0 (SOLUBLEACETYLCHOLINERECEPTOR) |
5fjv | NEURONALACETYLCHOLINERECEPTOR SUBUNITALPHA-2 (Homosapiens) | 4 / 8 | TYR A 122TRP A 178TYR A 219TYR A 226 | EPJ A 300 (-4.6A)EPJ A 300 (-3.7A)EPJ A 300 (-3.7A)EPJ A 300 (-3.7A) | 0.58A | 4bqtC-5fjvA:22.64bqtD-5fjvA:22.6 | 4bqtC-5fjvA:31.394bqtD-5fjvA:31.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5KXI_A_NCTA402_1 (NEURONALACETYLCHOLINERECEPTOR SUBUNITALPHA-4NEURONALACETYLCHOLINERECEPTOR SUBUNITBETA-2) |
5fjv | NEURONALACETYLCHOLINERECEPTOR SUBUNITALPHA-2 (Homosapiens) | 4 / 8 | TYR A 122TRP A 178THR A 179TYR A 226 | EPJ A 300 (-4.6A)EPJ A 300 (-3.7A)EPJ A 300 (-3.3A)EPJ A 300 (-3.7A) | 0.62A | 5kxiA-5fjvA:25.55kxiB-5fjvA:25.9 | 5kxiA-5fjvA:55.305kxiB-5fjvA:29.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5KXI_D_NCTD402_1 (NEURONALACETYLCHOLINERECEPTOR SUBUNITALPHA-4NEURONALACETYLCHOLINERECEPTOR SUBUNITBETA-2) |
5fjv | NEURONALACETYLCHOLINERECEPTOR SUBUNITALPHA-2 (Homosapiens) | 4 / 8 | TYR A 122TRP A 178THR A 179TYR A 226 | EPJ A 300 (-4.6A)EPJ A 300 (-3.7A)EPJ A 300 (-3.3A)EPJ A 300 (-3.7A) | 0.62A | 5kxiD-5fjvA:25.45kxiE-5fjvA:25.9 | 5kxiD-5fjvA:55.305kxiE-5fjvA:29.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6CNJ_D_NCTD402_1 (NEURONALACETYLCHOLINERECEPTOR SUBUNITALPHA-4NEURONALACETYLCHOLINERECEPTOR SUBUNITBETA-2) |
5fjv | NEURONALACETYLCHOLINERECEPTOR SUBUNITALPHA-2 (Homosapiens) | 4 / 8 | TYR A 122TRP A 178THR A 179TYR A 226 | EPJ A 300 (-4.6A)EPJ A 300 (-3.7A)EPJ A 300 (-3.3A)EPJ A 300 (-3.7A) | 0.68A | 6cnjD-5fjvA:23.36cnjE-5fjvA:24.1 | 6cnjD-5fjvA:59.386cnjE-5fjvA:21.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6CNK_A_NCTA405_1 (NEURONALACETYLCHOLINERECEPTOR SUBUNITALPHA-4) |
5fjv | NEURONALACETYLCHOLINERECEPTOR SUBUNITALPHA-2 (Homosapiens) | 4 / 6 | TYR A 122TRP A 178THR A 179TYR A 226 | EPJ A 300 (-4.6A)EPJ A 300 (-3.7A)EPJ A 300 (-3.3A)EPJ A 300 (-3.7A) | 0.68A | 6cnkA-5fjvA:23.56cnkB-5fjvA:16.9 | 6cnkA-5fjvA:59.386cnkB-5fjvA:59.38 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6CNK_B_NCTB402_1 (NEURONALACETYLCHOLINERECEPTOR SUBUNITALPHA-4NEURONALACETYLCHOLINERECEPTOR SUBUNITBETA-2) |
5fjv | NEURONALACETYLCHOLINERECEPTOR SUBUNITALPHA-2 (Homosapiens) | 4 / 7 | TYR A 122TRP A 178CSS A 221CSS A 222 | EPJ A 300 (-4.6A)EPJ A 300 (-3.7A)EPJ A 300 ( 4.2A)EPJ A 300 ( 4.2A) | 0.78A | 6cnkB-5fjvA:16.96cnkC-5fjvA:23.9 | 6cnkB-5fjvA:59.386cnkC-5fjvA:21.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6CNK_B_NCTB402_1 (NEURONALACETYLCHOLINERECEPTOR SUBUNITALPHA-4NEURONALACETYLCHOLINERECEPTOR SUBUNITBETA-2) |
5fjv | NEURONALACETYLCHOLINERECEPTOR SUBUNITALPHA-2 (Homosapiens) | 4 / 7 | TYR A 122TRP A 178CSS A 222TYR A 226 | EPJ A 300 (-4.6A)EPJ A 300 (-3.7A)EPJ A 300 ( 4.2A)EPJ A 300 (-3.7A) | 0.84A | 6cnkB-5fjvA:16.96cnkC-5fjvA:23.9 | 6cnkB-5fjvA:59.386cnkC-5fjvA:21.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6CNK_B_NCTB402_1 (NEURONALACETYLCHOLINERECEPTOR SUBUNITALPHA-4NEURONALACETYLCHOLINERECEPTOR SUBUNITBETA-2) |
5fjv | NEURONALACETYLCHOLINERECEPTOR SUBUNITALPHA-2 (Homosapiens) | 4 / 7 | TYR A 122TRP A 178CSS A 222TYR A 226 | EPJ A 300 (-4.6A)EPJ A 300 (-3.7A)EPJ A 300 ( 4.2A)EPJ A 300 (-3.7A) | 0.97A | 6cnkB-5fjvA:16.96cnkC-5fjvA:23.9 | 6cnkB-5fjvA:59.386cnkC-5fjvA:21.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6CNK_D_NCTD401_1 (NEURONALACETYLCHOLINERECEPTOR SUBUNITALPHA-4NEURONALACETYLCHOLINERECEPTOR SUBUNITBETA-2) |
5fjv | NEURONALACETYLCHOLINERECEPTOR SUBUNITALPHA-2 (Homosapiens) | 5 / 9 | TYR A 122TRP A 178THR A 179TYR A 219TYR A 226 | EPJ A 300 (-4.6A)EPJ A 300 (-3.7A)EPJ A 300 (-3.3A)EPJ A 300 (-3.7A)EPJ A 300 (-3.7A) | 0.75A | 6cnkD-5fjvA:23.46cnkE-5fjvA:24.1 | 6cnkD-5fjvA:59.386cnkE-5fjvA:21.78 |